IGC Pharma, Inc. — Director's Dealing 2016

Dec 20, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2016-12-16

Reporting Person: PRINS RICHARD K (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-04	Common stock	G	2000	—	Disposed	315000	Direct
2016-04-08	Common stock	G	2000	—	Disposed	313000	Direct
2016-04-15	Common stock	G	2000	—	Disposed	311000	Direct
2016-04-22	Common stock	G	2000	—	Disposed	309000	Direct
2016-04-29	Common stock	G	2000	—	Disposed	307000	Direct
2016-05-06	Common stock	G	2000	—	Disposed	305000	Direct
2016-05-13	Common stock	G	2000	—	Disposed	303000	Direct
2016-05-20	Common stock	G	2000	—	Disposed	301000	Direct
2016-05-27	Common stock	G	2000	—	Disposed	299000	Direct
2016-06-03	Common stock	G	2000	—	Disposed	297000	Direct
2016-06-10	Common stock	G	2000	—	Disposed	295000	Direct
2016-06-17	Common stock	G	8000	—	Disposed	287000	Direct
2016-07-08	Common stock	G	2000	—	Disposed	285000	Direct
2016-07-15	Common stock	G	2000	—	Disposed	283000	Direct
2016-07-22	Common stock	G	2000	—	Disposed	281000	Direct
2016-07-29	Common stock	G	2000	—	Disposed	279000	Direct
2016-08-05	Common stock	G	2000	—	Disposed	277000	Direct
2016-08-12	Common stock	G	2000	—	Disposed	275000	Direct
2016-08-19	Common stock	G	2000	—	Disposed	273000	Direct
2016-08-26	Common stock	G	2000	—	Disposed	271000	Direct
2016-09-02	Common stock	G	2000	—	Disposed	269000	Direct
2016-09-09	Common stock	G	2000	—	Disposed	267000	Direct
2016-09-16	Common stock	G	2000	—	Disposed	265000	Direct
2016-09-23	Common stock	G	2000	—	Disposed	263000	Direct
2016-09-30	Common stock	G	2000	—	Disposed	261000	Direct
2016-10-07	Common stock	G	2000	—	Disposed	259000	Direct
2016-10-14	Common stock	G	2000	—	Disposed	257000	Direct
2016-10-21	Common stock	G	2000	—	Disposed	255000	Direct
2016-10-28	Common stock	G	2000	—	Disposed	253000	Direct
2016-11-04	Common stock	G	2000	—	Disposed	251000	Direct